[HTML][HTML] Correlates of protection against SARS-CoV-2 in rhesus macaques
Recent studies have reported the protective efficacy of both natural 1 and vaccine-induced
2 , 3 , 4 , 5 , 6 – 7 immunity against challenge with severe acute respiratory syndrome …
2 , 3 , 4 , 5 , 6 – 7 immunity against challenge with severe acute respiratory syndrome …
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
…, K McMahan, SH Mahrokhian, JP Nkolola, J Liu… - Science, 2020 - science.org
The global coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …
syndrome coronavirus 2 (SARS-CoV-2) has made the development of a vaccine a top …
[HTML][HTML] COVID-19: immunopathogenesis and Immunotherapeutics
L Yang, S Liu, J Liu, Z Zhang, X Wan… - Signal transduction and …, 2020 - nature.com
The recent novel coronavirus disease (COVID-19) outbreak, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected patients …
syndrome coronavirus 2 (SARS-CoV-2), is seeing a rapid increase in infected patients …
Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women
…, J Feldman, M Gebre, EN Borducchi, J Liu… - Jama, 2021 - jamanetwork.com
Importance Pregnant women are at increased risk of morbidity and mortality from COVID-19
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …
[HTML][HTML] Immunogenicity of Ad26. COV2. S vaccine against SARS-CoV-2 variants in humans
G Alter, J Yu, J Liu, A Chandrashekar, EN Borducchi… - Nature, 2021 - nature.com
The Ad26.COV2.S vaccine 1 , 2 – 3 has demonstrated clinical efficacy against symptomatic
COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing …
COVID-19, including against the B.1.351 variant that is partially resistant to neutralizing …
[HTML][HTML] Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …
may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1 , 2 , 3 , 4 …
[HTML][HTML] Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
J Liu, A Chandrashekar, D Sellers, J Barrett… - Nature, 2022 - nature.com
The highly mutated SARS-CoV-2 Omicron (B.1.1.529) variant has been shown to evade a
substantial fraction of neutralizing antibody responses elicited by current vaccines that encode …
substantial fraction of neutralizing antibody responses elicited by current vaccines that encode …
[HTML][HTML] Immunogenicity of BA. 5 bivalent mRNA vaccine boosters
…, NP Hachmann, K McMahan, J Liu… - … England Journal of …, 2023 - Mass Medical Soc
Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
A Chandrashekar, J Liu, AJ Martinot, K McMahan… - Science, 2020 - science.org
An understanding of protective immunity to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global …
(SARS-CoV-2) is critical for vaccine and public health strategies aimed at ending the global …
Facets coupling of BiOBr-g-C3N4 composite photocatalyst for enhanced visible-light-driven photocatalytic activity
BiOBr-gC 3 N 4 inorganic–organic composite photocatalysts were synthesized by a one-step
chemical bath method at low temperature and characterized by X-ray diffraction patterns (…
chemical bath method at low temperature and characterized by X-ray diffraction patterns (…